NAPA Reauthorization Act

To extend the National Alzheimer’s Project. 1. Short title This Act may be cited as the NAPA Reauthorization Act 2. Extension of National Alzheimer’s project (a) Purpose of project Section 2(c) of the National Alzheimer’s Project Act ( 42 U.S.C. 11225(c) (1) in paragraph (2), by striking and coordination of on, and coordination of, (2) in paragraph (4)— (A) by redesignating subparagraphs (A) and (B) as subparagraphs (B) and (C), respectively; and (B) by inserting before subparagraph (B), as so redesignated, the following: (A) promotion of healthy aging and reduction and mitigation of risk factors for Alzheimer’s; ; (3) in paragraph (5)— (A) by inserting and other underserved populations, including individuals with developmental disabilities such as Down syndrome, populations (B) by striking ; and (4) by redesignating paragraph (6) as paragraph (7); and (5) by inserting after paragraph (5) the following: (6) provide information on, and promote the adoption of, healthy behaviors that may reduce the risk of cognitive decline and promote and protect cognitive health; and . (b) National plan Section 2(d)(2) of the National Alzheimer’s Project Act ( 42 U.S.C. 11225(d)(2) (1) by inserting , across public and private sectors, Nation’s progress (2) by inserting , including consideration of public-private collaborations, as appropriate (c) Advisory council Section 2(e) of the National Alzheimer’s Project Act ( 42 U.S.C. 11225(e) (1) in paragraph (2)— (A) in subparagraph (A), by adding at the end the following: (xi) A designee of the Department of Justice. (xii) A designee of the Social Security Administration. (xiii) A designee of the Federal Emergency Management Agency. (xiv) 2 or more other designees of the Department of Health and Human Services, at least one of whom has expertise in risk factors associated with the development or the progression of Alzheimer’s disease, as determined by the Secretary of Health and Human Services. ; and (B) in subparagraph (B)— (i) in the matter preceding clause (i), by striking 12 14 (ii) in clause (v)— (I) by striking 2 researchers 3 researchers (II) by striking ; and , including at least one researcher with demonstrated experience in recruitment and retention of underrepresented groups into research or clinical trials related to dementia; (iii) in clause (vi), by striking the period at the end and inserting ; and (iv) by adding at the end the following: (vii) 1 individual with a diagnosis of Alzheimer’s disease. ; (2) in paragraph (5)— (A) in subparagraph (A)— (i) by striking an initial evaluation annual evaluations (ii) by striking research, clinical research, risk reduction, public health, clinical (B) in subparagraph (B), by striking initial annual (C) in subparagraph (C)— (i) in the matter preceding clause (i), by striking initial annual (ii) in clause (ii), by inserting and reduce disparities (D) in subparagraph (D), by striking annually thereafter, an evaluation annual evaluations (3) in paragraph (6), by striking 2025 2035 (d) Annual report Section 2(g) of the National Alzheimer’s Project Act ( 42 U.S.C. 11225(g) (1) in paragraph (1)— (A) by striking that includes an evaluation that includes— (A) an evaluation ; (B) in subparagraph (A) (as so designated), by adding and (C) by adding at the end the following: (B) a summary of the Secretary’s process for identifying and updating what conditions constitute Alzheimer’s disease; ; and (2) in paragraph (3)(A)(ii), by inserting and reduce disparities (e) Sunset Section 2(h) of the National Alzheimer’s Project Act ( 42 U.S.C. 11225(h) 2025 2035 May 24, 2024 Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed

Summary: NAPA Reauthorization Act This bill extends through 2035 and makes other changes to the National Alzheimer's Project. This project supports coordination of federal planning, programs, and other efforts to address Alzheimer's disease and related dementias. In particular, the bill incorporates a focus on promoting healthy aging and reducing risk factors associated with cognitive decline. The bill also expands the Advisory Council on Alzheimer's Research, Care, and Services to include additional members, such as (1) a researcher with experience recruiting and retaining diverse clinical trial participants, (2) an individual diagnosed with Alzheimer's disease, and (3) representatives from additional federal agencies (e.g., the Department of Justice and the Office of Management and Budget).